Daily Dose - Mar 14th, 2024
 
 
Daily Dose | View online
 
March 14, 2024
This year, the FDA will make the call on groundbreaking treatments for conditions such as Alzheimer's, NASH, and pulmonary hypertension. Here's a look at important regulatory action dates to watch.
Sponsored

Process automation has evolved and instruments now offer integrated solutions such as Heartbeat Technology to facilitate the implementation of “Quality by Design” (QbD) and provide full regulatory compliance. This offers the possibility to reduce or even eliminate wet calibrations without putting product quality at risk.

The industry's largest biotech trade association is removing WuXi AppTec from its membership roster as it looks to clarify the organization's "strategic direction on national security."
The potential $1.05 billion deal will boost AstraZeneca's rare disease portfolio.
Sponsored
Learn how to identify common pitfalls in planning and scheduling processes, understand how to build a case for investing in maintenance planning, and discover strategies to optimize the availability of spare parts inventory for maintenance.